(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

At the Microsoft AI Tour in Seoul, Korean companies demonstrated how AI is moving beyond efficiency gains to become a true ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

A blood test that can detect a number of deadly cancers before symptoms develop is being trialled for potential use on the ...

ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.

The US National Security Commission on Emerging Biotechnology has warned China is in a position to create practically ...

Citizens JMP initiated coverage of Foghorn Therapeutics (FHTX) with an Outperform rating and $9 price target Foghorn is a clinical-stage ...